Krsnaa Diagnostics Limited (NSE:KRSNAA)
India
· Delayed Price · Currency is INR 672.80
-14.00 (-2.04%)
May 15, 2025, 3:29 PM IST
Krsnaa Diagnostics Revenue
In the fiscal year ending March 31, 2025, Krsnaa Diagnostics had annual revenue of 7.43B INR with 19.86% growth. Krsnaa Diagnostics had revenue of 1.90B in the quarter ending March 31, 2025, with 14.54% growth.
Revenue
7.43B
Revenue Growth
+19.86%
P/S Ratio
2.93
Revenue / Employee
2.01M
Employees
3,700
Market Cap
21.72B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 516.03B |
| Divi's Laboratories | 90.78B |
| Cipla | 271.45B |
| Mankind Pharma | 116.41B |
| Apollo Hospitals Enterprise | 211.46B |
| Zydus Lifesciences | 222.47B |
| Aurobindo Pharma | 309.22B |
| Alkem Laboratories | 127.57B |
Krsnaa Diagnostics News
- 22 days ago - Top stocks to buy today: Stock recommendations for April 23, 2025 - The Times of India
- 5 months ago - Lab stops blood collection at 400 BMC hosps over pending dues - The Times of India
- 7 months ago - Krsnaa Diagnostics shares surge nearly 6% as Q2 net sales reach ₹186.34 crore - Business Upturn
- 7 months ago - Stock in Focus: Krsnaa Diagnostics secures two major agreements in Ranchi - Business Upturn
- 8 months ago - Krsnaa Diagnostics to acquire 24% stake in start-up Apulki Healthcare - The Times of India
- 8 months ago - Krsnaa Diagnostics secures radiology services contract at Sadar Hospital, Ranchi - Business Upturn
- 8 months ago - Krsnaa Diagnostics acquires stake in India’s first PPP cancer and cardiac care hospitals - Business Upturn
- 8 months ago - Krsnaa Diagnostics share price surges over 3% after company agrees to acquire 23.53% stake in Apulki Healthcare - Business Upturn